CD34 and rheumatoid arthritis: Circulating CD34+ hematopoietic progenitor cells (PHCs), which play a central role in endothelial regeneration, were found to be significantly reduced in RA patients compared to healthy controls in a study by Lo Gullo et al., in which 24 RA patients and 26 matched controls took part.